Streamlining CAR-T Trials: Effective Supply Chain And QC Testing Through Collaborative Partnerships

Delivering personalized cell therapies on time requires more than scientific innovation—it demands seamless coordination across the entire supply chain. This webinar highlights how Vall d'Hebron Institute of Oncology (VHIO), the Blood and Tissue Bank of Catalonia (BST), and contract testing labs collaborate to manufacture and release retroviral vectors and CAR-T cell therapies for Phase 1 trials. With patient treatment timelines at risk, the teams share how they align on logistics, testing, and communication to reduce delays and uphold compliance. From cell collection to final QC release, gain a real-world look at the operational challenges and solutions behind early-phase cell therapy manufacturing.